Brown Advisory Inc Kala Pharmaceuticals, Inc. Transaction History

Brown Advisory Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 27, 2022	SELL	$1.16 - $2.74 $233,165 - $550,753	-201,005 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$8.33 - $13.79 $83,300 - $137,900	-10,000 Reduced 4.74%	201,005 $2.11 Million
Q2 2018 Aug 10, 2018	SELL	$13.3 - $17.49 $518,633 - $682,022	-38,995 Reduced 15.6%	211,005 $2.9 Million
Q1 2018 May 14, 2018	BUY	$12.26 - $18.98 $3.07 Million - $4.75 Million	250,000 New	250,000 $3.96 Million

Ticker KALA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,464,160
Market Cap $16.1M
Description
Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent...

Get notified when there are updates to the investment portfolio of Brown Advisory Inc, based on Form 13F filings with the SEC.

Stay updated on Brown Advisory Inc with notifications on news.